Johnson & Johnson bought the full rights to a rare disease gene therapy a few years ago, but now the Big Pharma may be ...

McEvoy is a President, Chief Executive Officer & Director at Insulet Corp., an Independent Director at Procter & Gamble Co., an Assistant Manager-Brand at McNeil Consumer Healthcare and a Chairman & ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The global cataract surgery device market is poised for significant growth, projected to expand from USD 8,928 million in 2024 to an estimated USD 12,472.70 million by 2034. This robust increase, ...

The company has predicted that Imaavy — now approved for myasthenia gravis — could eventually earn more than $5 billion in ...

ACTON, Mass. – Insulet has appointed Ashley McEvoy as president and CEO effective immediately. She succeeds Jim Hollingshead, who has agreed to end his employment at the company and resign from its ...

Warren Buffett has retained that capacity. As Berkshire Hathaway’s annual shareholder meeting on May 3rd drew to a close, Mr ...

The project, more than a decade in the making, replaces a business campus that was once home to Johnson & Johnson, Pfizer and ...

It isn't the first drug in the class to be cleared by the FDA for gMG – Argenx and UCB have FcRn blockers already on the ...

The in-depth feature also spotlights Nutu, Willow Labs' science-backed "nudge" platform that empowers people with ...